Effect of alpha lipoic acid on ifosfamide-induced central neurotoxicity in rats

References

• Rzeski W, Pruskil S, Macke A, Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol 2004;56:351–60.
   PubMedGoogle Scholar
• Varan A, Kebudi R. Secondary malignant neoplasms after childhood cancer. Pediatr Hematol Oncol 2011;28:345–53.
   PubMed Web of Science ®Google Scholar
• Kaijser GP, Beijnen JH, Bult A, Ifosfamide metabolism and pharmacokinetics (review). Anticancer Res 1994;14: 517–31.
   PubMed Web of Science ®Google Scholar
• Klastersky J. Side effects of ifosfamide. Oncology 2003; 65(Suppl 2):7–10.
   PubMed Web of Science ®Google Scholar
• Sioka C, Kyritsis AP. Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol 2009;63:761–7.
   PubMed Web of Science ®Google Scholar
• Imtiaz S, Muzaffar N. Ifosfamide neurotoxicty in a young female with a remarkable response to thiamine. J Pak Med Assoc 2010;60:867–9.
   PubMed Web of Science ®Google Scholar
• Nicolao P, Giometto B. Neurological toxicity of ifosfamide. Oncology 2003;65(Suppl 2):11–6.
   Google Scholar
• Flamant F, Rodary C, Rey A, Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 1998;34:1050–62.
   PubMed Web of Science ®Google Scholar
• Pratt CB, Green AA, Horowitz ME, Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna. J Clin Oncol 1986;4:1253–61.
   PubMed Web of Science ®Google Scholar
• Huang Z, Roy P, Waxman DJ. Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide. Biochem Pharmacol 2000;59:961–72.
   PubMed Web of Science ®Google Scholar
• McVay JI, Wood AM. Suspected ifosfamide-induced neurotoxicity. Pharmacotherapy 1999;19:1450–5.
   PubMed Web of Science ®Google Scholar
• Kupfer A, Aeschlimann C, Wermuth B, Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet 1994;343:763–4.
   PubMed Web of Science ®Google Scholar
• Ajithkumar T, Parkinson C, Shamshad F, Ifosfamide encephalopathy. Clin Oncol (R Coll Radiol) 2007;19:108–14.
   PubMed Web of Science ®Google Scholar
• Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 2007;47:629–56.
   PubMed Web of Science ®Google Scholar
• Dincer Y, Telci A, Kayali R, Effect of alpha-lipoic acid on lipid peroxidation and anti-oxidant enzyme activities in diabetic rats. Clin Exp Pharmacol Physiol 2002;29:281–4.
   PubMed Web of Science ®Google Scholar
• Teichert J, Hermann R, Ruus P, Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. J Clin Pharmacol 2003;43:1257–67.
   PubMed Web of Science ®Google Scholar
• Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997;29:315–31.
   PubMedGoogle Scholar
• Bilska A, Wlodek L. Lipoic acid - the drug of the future? Pharmacol Rep 2005;57:570–7.
   PubMed Web of Science ®Google Scholar
• dos Santos PS, Feitosa CM, Saldanha GB, Lipoic acid inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after pilocarpine-induced seizures. Pharmacol Biochem Behav 2011;97:531–6.
   Google Scholar
• Cadirci E, Altunkaynak BZ, Halici Z, Alpha-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and puncture-induced sepsis model in rats. Shock 2010;33:479–84.
   PubMed Web of Science ®Google Scholar
• Irmak MK, Koltuksuz U, Kutlu NO, The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with alpha-tocopherol in rat kidneys. Urol Res 2001;29:190–3.
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193: 265–75.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase. In: Bergmeyer HU (ed). Methods of enzymatic analysis. New York and London: Academic Press; 1974; 673– 677.
   Google Scholar
• Levine RL, Garland D, Oliver CN, Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464–78.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407–21.
   PubMed Web of Science ®Google Scholar
• Kupfer A, Aeschlimann C, Cerny T. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy. Eur J Clin Pharmacol 1996;50:249–52.
   PubMed Web of Science ®Google Scholar
• Kim DW, Kim DS, Kim MJ, Imipramine enhances neuroprotective effect of PEP-1-Catalase against ischemic neuronal damage. BMB Rep 2011;44:647–52.
   Google Scholar
• Jesudason EP, Masilamoni JG, Jesudoss KS, The protective role of DL-alpha-lipoic acid in the oxidative vulnerability triggered by abeta-amyloid vaccination in mice. Mol Cell Biochem 2005;270:29–37.
   PubMedGoogle Scholar
• Akyol O, Herken H, Uz E, The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:995–1005.
   PubMed Web of Science ®Google Scholar
• Ozturk E, Demirbilek S, Kadir But A, Antioxidant properties of propofol and erythropoietin after closed head injury in rats. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:922–7.
   PubMed Web of Science ®Google Scholar
• Fadillioglu E, Gursul C, Iraz M. Effects of caffeic acid phenethyl ester on thioacetamide-induced hepatic encephalopathy in rats. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1440–5.
   PubMed Web of Science ®Google Scholar
• Holmquist L, Stuchbury G, Berbaum K, Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther 2007;113:154–64.
   PubMed Web of Science ®Google Scholar
• Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995;19:227–50.
   PubMed Web of Science ®Google Scholar
• Perera J, Tan JH, Jeevathayaparan S, Neuroprotective effects of alpha lipoic acid on haloperidol-induced oxidative stress in the rat brain. Cell Biosci 2011;1:12.
   PubMedGoogle Scholar
• Wang X, Zhang X, Cheng Y, Alpha-lipoic acid prevents bupivacaine-induced neuron injury in vitro through a PI3K/Akt-dependent mechanism. Neurotoxicology 2010;31:101–12.
   PubMed Web of Science ®Google Scholar
• Farr SA, Poon HF, Dogrukol-Ak D, The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 2003;84:1173–83.
   PubMed Web of Science ®Google Scholar
• Pirlich M, Kiok K, Sandig G, Alpha-lipoic acid prevents ethanol-induced protein oxidation in mouse hippocampal HT22 cells. Neurosci Lett 2002;328:93–6.
   PubMedGoogle Scholar
• Aguirre N, Barrionuevo M, Ramirez MJ. et al. Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity. Neuroreport 1999;10:3675–80.
   PubMed Web of Science ®Google Scholar
• Muller U, Krieglstein J. Prolonged pretreatment with alpha-lipoic acid protects cultured neurons against hypoxic, glutamate-, or iron-induced injury. J Cereb Blood Flow Metab 1995;15:624–30.
   PubMed Web of Science ®Google Scholar
• Nagesh Babu G, Kumar A, Singh RL. Chronic pretreatment with acetyl-L-carnitine and +/-DL-alpha-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function. Neurotox Res 2011;19:319–29.
   PubMed Web of Science ®Google Scholar
• Melli G, Taiana M, Camozzi F, Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol 2008;214:276–84.
   PubMed Web of Science ®Google Scholar
• Pederzolli CD, Rosa AP, de Oliveira AS, Neuroprotective role of lipoic acid against acute toxicity of N-acetylaspartic acid. Mol Cell Biochem 2010;344:231–9.
   Google Scholar
• Mates JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000;153:83–104.
   PubMed Web of Science ®Google Scholar